Heart disease risk can indicate long-term COPD fate

May 2, 2012

A simple test for heart disease risk can go a long way toward determining the long-term prognosis for people with chronic obstructive pulmonary disease, according to UC Irvine researchers.

Dr. Hwa Mu Lee and Nathan Wong of the UCI Prevention Program found that individuals with moderate to severe COPD who had a low Framingham Heart Study 10-year risk assessment rate lived longer and healthier than COPD patients who scored high on the heart test.

Study results point to the importance of cardiovascular health for those with COPD and strongly suggest that heart disease risk evaluations be part of the diagnostic and treatment procedures for such as emphysema and bronchitis that affect 64 million people worldwide and are the third-leading cause of death in the U.S.

"There is a close connection between COPD and cardiovascular events like heart attacks, but too often physicians who see COPD patients do not assess the impact of factors as part of a treatment plan," said Lee, associate research director of the UCI program and an assistant clinical professor of medicine specializing in pulmonary and critical care.

"We're learning that addressing may significantly improve outcomes in persons with COPD," added Wong, program director and a professor of cardiology and epidemiology. "The connection between these two diseases is underappreciated."

Lee and Wong examined the severity of COPD in 6,266 U.S. adults over 40 in relation to their 10-year .

They noted that there are current National Institutes of Health-funded studies on whether statins – cholesterol-lowering drugs often prescribed for heart patients – can help lessen COPD-related lung inflammation.

Janet Lee, Katherine Lee and Yanting Luo of UCI, as well as Dr. Don Sin of St. Paul's Hospital in Vancouver, also contributed to the study, which appears online in the journal Chest.

Explore further: Heart health impacts wellbeing of patients with chronic obstructive pulmonary disease

Related Stories

Heart health impacts wellbeing of patients with chronic obstructive pulmonary disease

October 14, 2011
A new study has found that processes that control heart rate play an important role in the quality of life experienced by patients with chronic obstructive pulmonary disease (COPD). The study, which was published in the journal ...

New evidence highlights risk of comorbidities for COPD patients

September 26, 2011
A new study has shown that people with chronic obstructive pulmonary disease (COPD) or people with reduced lung function are at a serious risk of developing cardiovascular disease.

Long-term use of vitamin E may cut COPD risk

June 16, 2011
Long-term, regular use of vitamin E in women 45 years of age and older may help decrease the risk of chronic obstructive pulmonary disease (COPD) by about 10 percent in both smokers and nonsmokers, according to a study conducted ...

Beta blockers may help COPD sufferers

May 12, 2011
(Medical Xpress) -- Beta blockers, the group of drugs commonly prescribed to patients with heart diseases, may also have considerable benefits for sufferers of diseases such as chronic bronchitis and emphysema, according ...

Children exposed to cigarette smoke have increased risk of COPD in adulthood

March 15, 2012
A new study published in the journal Respirology reveals that children who are exposed to passive smoke have almost double the risk of developing chronic obstructive pulmonary disease (COPD) in adulthood compared with non-exposed ...

Recommended for you

Co-infection with two common gut pathogens worsens malnutrition in mice

July 27, 2017
Two gut pathogens commonly found in malnourished children combine to worsen malnutrition and impair growth in laboratory mice, according to new research published in PLOS Pathogens.

Finish your antibiotics course? Maybe not, experts say

July 27, 2017
British disease experts on Thursday suggested doing away with the "incorrect" advice to always finish a course of antibiotics, saying the approach was fuelling the spread of drug resistance.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.